Subscribe to Newsletter

November 2019 Issue of The Cannabis Scientist

Time to abandon our grow rooms? To find out, we speak with leading figures to explore the rise of synthetic biology in cannabinoid production. Our In My View section has a focus on the legislative hurdles hindering research either side of the Atlantic. Mark Barnes reflects on the state of medical cannabis and government policy in the UK in this month’s Sitting Down With. Evolving policy, however, presents evolving challenges, such as the need for roadside THC testing and cannabis education – efforts detailed in our upfront section.

Register to download
Register here to download any issue of The Cannabis Scientist for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Cannabis Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Research & Development Medical research

Powering Up Cannabis Clinical Trials

| Charlotte Barker

The message is clear: we need more evidence. But are randomized, controlled trials the answer?
Research & Development Neurology & psychology

Balancing Act

| Matthew Hallam

Does CBD really counteract the neuropsychiatric risks of THC?
Testing & Processing Cannabinoid analysis

Carbon Nanotubes for Cannabis Control

| Jonathan James

Freeing the roads of THC-intoxicated drivers, one breathalyzer test at a time
Business & Profession Education

Cannabis 101

| Jonathan James

Training the cannabis scientists of tomorrow has never been more important
Research & Development Medical research

Jump into the Patient Pool: The Data's Lovely

| Jonathan James

How are Canadians using medical cannabis?
Business & Profession Legislation & policy

The View from Texas

| Kevin Schug

Restrictive legislation won’t prevent efforts to progress cannabis research
Business & Profession Legislation & policy

Vape Flavor Regulation: a Sour Taste in the Mouth?

| Brad Douglass

Regulating cannabis vape flavors may have negative consequences for wider cannabis research… Unless industry acts quickly
Research & Development Tools & technology

The Cannabinoid Factories of the Future

| Matthew Hallam

Could synthetic biology facilitate a microbial revolution... and do away with grow rooms for good?
Business & Profession Legislation & policy

Cannabis in the UK: From Policy to Practice

Sitting Down With... Mike Barnes, Chief Medical Officer, Lyphe Group, London, UK and Chairman, Maple Tree Consultancy, Chester, UK.

Other issues of 2019